About Us
CELforPharma stands for Centre for Executive Leadership for the Pharmaceutical Industry. Our aim is to develop the market leadership capabilities of executives in the pharma industry and related sectors with training by top-notch international experts on business-critical competencies.
The company was founded in 2005 by Luc De Langhe and Edouard Demeire after they discovered an interesting niche in pharma’s landscape for executive training: short duration courses by esteemed experts on business-critical topics, i.e. topics that impact business growth and/or strategic decisions.
Read More: Our Company History | Our Experts | Our Team
What We Do
CELforPharma organises short duration open enrolment training courses on business critical competencies specific to the pharma industry and related sectors. All of our courses are designed with, and taught by, an exclusive network of experts who are internationally recognised by their peers as opinion leaders in their field of expertise. These experts are sought-after by the industry for complex consulting projects and therefore have limited time for public speaking.
Read More: 8 Reasons Why You Should Attend a CELforPharma Training Course
Who Attends Our Executive Training Courses
CELforPharma’s executive education courses are attended by pharma, biotech and other life science industry professionals. While the majority of our delegates come from Europe, many travel from beyond: USA, Middle & Far East, Russia, Turkey etc.
Therefore, when you decide to attend one of our short-duration courses, you will additionally benefit from interacting with pharma peers from other geographical and therapeutic markets, as well as with executives from other industry sectors such as biotech, medical devices, diagnostics and professional services.
How We Fit in the Pharma Industry
The research-based pharmaceutical industry is squeezed between an external threat and an internal weakness:
The Threat: healthcare systems make it increasingly difficult to secure reimbursement and patient access for new pharmaceuticals at a viable price.
The Weakness: the industry’s overall R&D productivity is, despite a very dynamic biotech industry, insufficient to fill the pipelines with truly innovative compounds with blockbuster potential.
To address this strategic challenge, the industry needs to equip executives with new competencies to:
- Close more and better business development and licensing deals in R&D
- Optimise market access for new brands
- Leverage the power of the internet
- Improve patient engagement and patient adherence to therapy
- Select the best lifecycle management strategies for established/mature brands
Thus, we have developed our courses to help address these challenges and teach new competencies needed to succeed. Our course topics include:
Market Access, Pricing & Health Economics
- Principles of Pharma Market Access in Europe
- Value Pricing for Market Access – The Essentials
- Health Economics for Non-Health-Economists
- The Health Technology Assessment Course - Fundamentals, Trends & Opportunities
- Fundamentals of RWE for Optimising Market Access
Medical Affairs
- Medical Affairs for Modern Pharma - New Challenges & Competencies
- The Strategic e-Medical Affairs Course
- Business Acumen for Medical Science Liaisons
- Understanding Patient Behaviour & Developing Personalised Solutions
- The Multi-Channel Patient Engagement Course
Strategic Pharma Marketing
- The Strategic Digital Pharma Marketing Course
- The Multi-Channel Patient Engagement Course
- The Pharma Brand Planning Course
- The Pharma Forecasting Course
- Late Stage Pharma Lifecycle Management
- Personalising Patient Experiences Using Behavioural Science
- Strategy & Planning for Commercial Launch Success in Pharma - A Cross-functional Approach
- Strategic Account Management in Pharma - Driving Value in Your Accounts Through Triple-Win Strategies
Business Development & Licensing
- The Pharma Business Development Course - An Overview Course
- The Pharmaceutical Out-licensing Course - For R&D-based Products
- The Pharma Licensing Negotiation Course
- Pharma-Biotech Product & Company Valuation - An Introductory Course
- The Pharma Forecasting Course
